Could SBRT Have Role in Metastatic Kidney Cancer?

June 28, 2017

This video examines a pilot trial that tested stereotactic body radiotherapy plus nephrectomy in patients with renal cell carcinoma.

In this video, Thomas Schwaab, MD, PhD, of Roswell Park Cancer Institute in Buffalo, New York, discusses a pilot trial that tested stereotactic body radiotherapy (SBRT) plus nephrectomy in patients with renal cell carcinoma.

The research, which was published in Clinical Cancer Research, also provides evidence that immunotherapy may be an effective third element to this combination.

Video courtesy of Roswell Park Cancer Institute.